首页> 外文OA文献 >Rapid inactivation of the plasminogen-activator inhibitor upon secretion from cultured human endothelial cells.
【2h】

Rapid inactivation of the plasminogen-activator inhibitor upon secretion from cultured human endothelial cells.

机译:从培养的人内皮细胞分泌后,纤溶酶原激活物抑制剂迅速失活。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In conditioned medium (CM) from cultured human endothelial cells, two forms of plasminogen-activator inhibitor (PA-inhibitor) can be demonstrated: a fast-acting active form and an immunologically related, inactive form. Evidence is presented that endothelial cells produce active PA-inhibitor which is rapidly inactivated upon secretion into the medium. This inactivation can, at least partly, be prevented by culturing cells with excess of tissue-type plasminogen activator (t-PA). This results in the formation of large amounts of t-PA-PA-inhibitor complex at the cost of accumulation of inactive PA-inhibitor. No complex was detectable when inactive PA-inhibitor preparations were incubated with t-PA either in the absence or in the presence of cells. Furthermore, in cell extracts, predominantly functionally active PA-inhibitor was present. PA-inhibitor derived from the t-PA-PA-inhibitor complex showed an Mr approx. 4000 lower by polyacrylamide-gel electrophoresis than that of the inactive form. The rapid inactivation seems to be confined to newly synthesized molecules, since PA-inhibitor molecules in CM are inactivated much more slowly (even with cells or cell homogenates) than necessary to explain the excessive production of inactivated PA-inhibitor by cells. It could not be prevented by inhibitors of oxidative processes, like butylated hydroxytoluene, dithiothreitol, superoxide dismutase and catalase.
机译:在来自培养的人内皮细胞的条件培养基(CM)中,可以证明两种形式的纤溶酶原激活物抑制剂(PA抑制剂):速效活性形式和免疫学相关的非活性形式。证据表明内皮细胞产生活性的PA抑制剂,该抑制剂在分泌到培养基中后会迅速失活。通过用过量的组织型纤溶酶原激活物(t-PA)培养细胞可以至少部分地防止这种失活。这导致大量t-PA-PA-抑制剂复合物的形成,但以惰性PA-抑制剂的积累为代价。在无细胞或有细胞的情况下,将无活性PA抑制剂制剂与t-PA孵育时,均未检测到复合物。此外,在细胞提取物中,存在主要是功能活性的PA抑制剂。衍生自t-PA-PA抑制剂复合物的PA抑制剂的Mr约为1。聚丙烯酰胺-凝胶电泳比非活性形式低4000倍。快速失活似乎仅限于新合成的分子,因为CM中的PA抑制剂分子的失活速度比解释细胞过度产生灭活的PA抑制剂所需的灭活速度要慢得多(即使使用细胞或细胞匀浆)。它不能通过氧化过程的抑制剂来防止,例如丁基化羟基甲苯,二硫苏糖醇,超氧化物歧化酶和过氧化氢酶。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号